Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $1079.28
TAXUS benefits demonstrated in non-diabetic patient population carry over into insulin-treated diabetic patients NATICK, Mass., and PARIS, May 17...
Shareholder Views 'Anything Less than $71 Per Share from J&J' As Unacceptable NEW YORK, Jan. 10 /PRNewswire/ -- Elliott Associates, L.P...
/C O R R E C T I O N -- Corautus Genetics Inc./ In the news release, Corautus Genetics Inc. Announces Publication of Positive Gene Therapy Trial...
/C O R R E C T I O N -- Corautus Genetics Inc./ In the news release, Corautus Genetics to Present at the Rodman & Renshaw Healthcare Conference...
Leerink Swann & Company Resumes Coverage of Boston Scientific Corporation (NYSE: BSX) BOSTON, Sept. 28 /PRNewswire/ -- This morning, Senior...
Boston Scientific Announces Preliminary Information on U.S. TAXUS Sales for May 1 - 14 NATICK, Mass., May 18 /PRNewswire/ -- Boston Scientific...
Alternatives to Hysterectomies: Women Are Urged to Know Their Options When It Comes to Treating Certain Conditions NEW YORK, May 10 /PRNewswire/...
Boston Scientific to Participate in CIBC Conference NATICK, Mass., Nov. 3 /PRNewswire/ -- Boston Scientific Corporation is scheduled to...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.